El interés en corto de Qualigen Therapeutics da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Qualigen Therapeutics. Los datos de interés en corto se actualizan cada dos semanas.

Qualigen Therapeutics (NASDAQ:QLGN) Bolsa, Informe de interés en corto

Qualigen Therapeutics

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Earnings

Equities

News

Eurozone

Markets

Trading Ideas

APLD

EAST

HOTH

Qualigen Therapeutics, Inc. - Common Stock

QLGN

SGLY

SIFY

Mercados mixtos en EE.UU. el jueves, con el Nasdaq subiendo un 0,2% y Dow Jones ganando un 0,06%. Sectores de consumo lideran alzas.

Mercados mixtos mientras los subsidios por desempleo de EEUU caen

Qualigen Therapeutics Inc

2. FY25 forecast: Revenue ¥5,400.0 bn (+¥10.0 bn compared to the previous announcement), Operating Profit ¥400.0 bn (unchanged from the previous announcement)
- Due mainly to foreign exchange rates reconsidered in line with the weaker yen, revenue is expected to exceed the previous announcement.
- Mitsubishi Electric Group will steadily implement ongoing initiatives to improve profitability and efficiency in each business.

Guidance

MIELF

MIELY

Mitsubishi Electric Revises FY25 Revenue Forecast To ¥5.4T, Maintains Operating Profit at ¥400B

Mitsubishi Electric Q3 Sales ¥1.356T ($8.81B) Up From ¥1.243T YoY; Net Profit Attributable Stockholders ¥129.4B Up From ¥65.8B YoY

Investor sentiment remained positive in the fourth quarter of 2024, driving strong institutional and private client activity supported by a constructive market backdrop that reflected an increase in investors' risk appetite following the results of the US presidential election.&nbsp;
Constructive market conditions have continued into the first quarter of 2025 sustained by the greater optimism regarding growth prospects in the US. However, investor behavior may be affected by the clouded macroeconomic outlook outside the US, increased uncertainties around global trade, inflation and central bank policies, as well as geopolitics, including the upcoming elections in Germany. We see the markets as remaining particularly sensitive to new developments, positive or negative, leading to potential spikes in volatility across all asset classes.&nbsp;
In the first quarter, we expect a low-to-mid single digit percentage sequential decline in net interest income (NII) in Global Wealth Management and around a 10% sequential decline in Personal &amp; Corporate Banking's NII, measured in Swiss francs. Higher asset levels are expected to support recurring fee income across our asset-gathering businesses. As we progress our integration plans, integration-related expenses are expected to be around USD 1.1bn and accretion of PPA effects to contribute around USD 0.5bn to the Group's total revenues.&nbsp;
We remain focused on supporting clients with advice and solutions and continue to execute on our priorities, investing in people, products, and capabilities to drive sustainable long-term value for our stakeholders while maintaining a balance sheet for all seasons.

UBS Forecasts Q1 Decline In Net Interest Income Amid Integration Costs And Strategic Investments

In response to the United States&#8217; unilateral decision to impose a 10% tariff on all Chinese goods, China has announced its intention to retaliate by imposing tariffs on certain US imports.
What Happened: The State Council Customs Tariff Commission announced on Tuesday that it will be imposing tariffs on certain US imports, effective from Feb. 10. The decision comes in response to the U.S. government&#8217;s decision to levy a 10% tariff on all Chinese goods.
According to the announcement, the tariffs will be as follows:
1. A 15% tariff on coal and liquefied natural gas (LNG).
2. A 10% tariff on crude oil, agricultural machinery, high-displacement vehicles, and pickup trucks.
3. Additional tariffs will be imposed on the listed U.S. imports, on top of the existing rates. The current tax exemption and reduction policies will remain unchanged, and the additional tariffs will not be subject to reduction.
SEE ALSO:&nbsp;<a href="https://in.benzinga.com/25/02/43452717/nvidia-tsmc-drop-as-trump-hits-mexico-canada-and-china-with-tariffsbut-top-analyst-sees-only-limited-supply-chain-impact">Nvidia, TSMC Stocks Fell As Trump Hit Mexico, Canada, And China With Tariffs—But Top Analyst Sees Only &#8216;Limited&#8217; Supply Chain Impact On Chips</a>
The announcement was made according to the laws of the People&#8217;s Republic of China, including the Customs Law, the Foreign Trade Law, and international legal principles. The decision was approved by the State Council.
In a separate statement, officials from the Chinese Commerce Ministry and customs announced the implementation of export controls on items related to tungsten, tellurium, ruthenium, and molybdenum.
Why It Matters: The decision by China to impose tariffs on select US imports comes in response to the US government&#8217;s decision to levy a 10% tariff on all Chinese goods. This move is part of the ongoing trade tensions between the two economic powerhouses, which have been escalating in recent years.
President Donald Trump&#8216;s tariffs on Canada, Mexico, and China are predicted to <a href="https://www.benzinga.com/news/global/25/02/43442219/why-beer-tequila-avocados-cars-iphone-prices-could-rise-trumps-tariffs-on-canada-mexico-china-to-hurt-several-sectors">impact several sectors</a> and potentially lead to retailers and companies raising prices on consumers to offset the higher prices.
Renowned economist and Obama-era Treasury Secretary, Lawrence Summers, criticized President Trump's recent tariff impositions, <a href="https://www.benzinga.com/25/02/43425160/trump-tariffs-a-strategic-gift-to-xi-jinpings-china-says-obama-era-treasury-secretary-jobs-in-industrial-heartland-will-be-lost">describing them as a "bully strategy"</a> that could have far-reaching negative impacts.
Among crude oil and LNG exporters, companies like Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>), Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>), and ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>), which have significant exports to China, could see higher costs due to the new tariffs. Similarly, U.S. automakers such as General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) and Ford (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>), which sell vehicles in China, may encounter new challenges.
<ul>
<li>READ NEXT: <a href="https://www.benzinga.com/tech/25/02/43453553/palantirs-shyam-sankar-us-is-at-war-with-china-in-ai-and-the-time-to-act-was-yesterday">Palantir&#8217;s Shyam Sankar: US Is At War With China In AI—And The Time To Act Was &#8216;Yesterday&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image Via Shutterstock

Macro Economic Events

Economics

China Strikes Back: New Tariffs Up To 15% On Certain US Imports In Retaliation For Trump's 10% Levy On Chinese Goods

UBS Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBS#NYSE">UBS</a>) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.22 by 4.55 percent. This is a 355.56 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $11.635 billion which beat the analyst consensus estimate of $11.171 billion by 4.15 percent. This is a 7.19 percent increase over sales of $10.855 billion the same period last year.

Earnings Beats

UBS Gr Q4 2024 GAAP EPS $0.23 Beats $0.22 Estimate, Sales $11.635B Beat $11.171B Estimate

<ul>
<li>Dassault Systèmes' 3DEXPERIENCE platform on the cloud becomes a foundational technology solution at Volkswagen Group to advance vehicle development</li>
<li>Virtual twin experiences reduce engineering and manufacturing cycles of complex automotive systems, streamline workflows, optimize resources and accelerate time-to-market</li>
</ul>

DASTY

VLVLY

Volkswagen Partners With Dassault Systèmes To Leverage Cloud-Based 3DEXPERIENCE Platform For Smarter, Faster Car Development

Tyson Foods Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSN#NYSE">TSN</a>) reported better-than-expected first-quarter results, driven by robust performance in the chicken sales segment. This marks the company&#8217;s third consecutive quarter of annual growth across key metrics.
What Happened: The company <a href="https://www.benzinga.com/news/earnings/25/02/43432806/tyson-foods-posts-q1-earnings-protein-conscious-customers-drive-demand-ceo-calls-it-best-quarter-in-2-years">reported</a> earnings of $1.14 per share beating the Benzinga consensus <a href="https://www.benzinga.com/quote/TSN/earnings">estimate</a> of $0.88 by 29.5% and sales of $13.62 billion, 1.21% above the estimated $13.46 billion for the first quarter of fiscal 2025.
"Our best quarterly performance in more than two years reflects improved execution across the business, including exceptional results in chicken," said president and CEO Donnie King.
The management during its earnings call highlighted that its diversified multi-protein portfolio delivered results, with chicken helping to offset the ongoing challenges in beef. Achieving the best adjusted operating income of any quarter over the past eight years in the chicken segment.
The company&#8217;s value-added products like Jimmy Dean griddle cakes and chicken biscuits gained traction as chicken also continued to be a &#8220;bright spot,&#8221; with sales increasing due to higher volumes in these foodservice channels, explained the company CFO Curt Calaway.
Calaway raised adjusted operating income guidance for the segment to $1 billion to $1.3 billion for fiscal 2025, given the chicken&#8217;s strong first-quarter performance.
Highlighting the concerns regarding the trade war with Mexico, King added &#8220;Mexico is a large trading partner for us. So, essentially, what we would do, whether it be pork or whether it would be chicken, is we would find other markets.&#8221;
See Also: <a href="https://www.benzinga.com/news/earnings/25/02/43432806/tyson-foods-posts-q1-earnings-protein-conscious-customers-drive-demand-ceo-calls-it-best-quarter-in-2-years">Tyson Foods Posts Q1 Earnings: Protein Conscious Customers Drive Demand, CEO Calls It Best Quarter In 2 Years</a>
Why It Matters: Despite strong growth in the Chicken segment in the first quarter, the Centers for Disease Control and Prevention (CDC) on its website highlighted that H5 bird flu is widespread in wild birds globally, causing outbreaks in poultry and U.S. dairy cows, with recent human cases in U.S. farm workers. The public health risk remains low, but the CDC is closely monitoring the situation and people exposed to animals, using its flu surveillance systems.
CDC&#8217;s weekly scientific reports are on hold due to an "immediate pause" on communications by federal health agencies, ordered by Dorothy Fink, acting secretary of the Department of Health and Human Services. CNN <a href="https://edition.cnn.com/2025/01/30/health/bird-flu-mmwr-pause-trump-kff-partner/index.html">reported</a> that Fink&#8217;s memo, issued on President Donald Trump's first full day in office, requires any publication to be reviewed and approved by a presidential appointee. 
Price Action: Shares of Tyson Foods rose 2.21% to end Monday at $57.74 apiece. It fell by 0.24% in after-hours. The exchange-traded fund tracking Russell 2000, iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) declined 1.17% to $223.83 on Monday.
The average price target among 17 analysts <a href="https://www.benzinga.com/quote/TSN/analyst-ratings">tracked by Benzinga</a> is $61.38 with a ‘sell' rating. The estimates range from $45 to $75 apiece. Recent ratings from Barclays, UBS, and Piper Sandler suggest a $65 target, implying a potential upside of 12.85%.
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/quote/TSN/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="384" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04005115/Tyson-ANR-1024x384.png" alt="" class="wp-image-764001" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04005115/Tyson-ANR-1024x384.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04005115/Tyson-ANR-300x112.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04005115/Tyson-ANR-768x288.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/04005115/Tyson-ANR.png 1060w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/02/43431874/billionaire-ray-dalio-raises-valuation-concerns-as-deepseeks-new-model-hits-nvidia-stock-a-great-company-that-gets-expensive-is-much-worse-than-a-bad-company-thats-really-cheap">Billionaire Ray Dalio Raises Valuation Concerns As DeepSeek&#8217;s New Model Hits Nvidia Stock: &#8216;A Great Company That Gets Expensive Is Much Worse Than A Bad Company That&#8217;s Really Cheap&#8217;</a></li>
</ul>

Market Summary

Broad U.S. Equity ETFs

ETFs

General

Winner Winner, Chicken Dinner: Tyson Foods Q1 Beat Showcases 'Improved Execution' In Poultry, Says CEO

Flex LNG (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLNG#NYSE">FLNG</a>) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.56 by 1.79 percent. This is a 18.57 percent decrease over earnings of $0.70 per share from the same period last year. The company reported quarterly sales of $90.934 million which beat the analyst consensus estimate of $90.000 million by 1.04 percent. This is a 6.48 percent decrease over sales of $97.234 million the same period last year.

FLNG

Flex LNG Q4 2024 Adj. EPS $0.57 Beats $0.56 Estimate, Sales $90.934M Beat $90.000M Estimate

EV giant Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) had 203,221 vehicle registrations in California in 2024, nearly 12% lower than the year before, according to recent industry data.
What Happened: &#8220;Things aren't looking so golden for EV automaker Tesla in the Golden State. Tesla's dominance in the electric vehicle market continues to falter as the brand reported its fifth consecutive quarterly registration decline,&#8221; the California New Car Dealers Association (CNCDA)&nbsp; said in a statement. 
Tesla&#8217;s new registrations fell 7.8% in the fourth quarter and 11.6% in 2024. For the year, Tesla held a 52.5% share of the zero-emission vehicle market, down from the 60.1% share in 2023.
Tesla&#8217;s Model Y SUV, however, was the best-selling battery electric vehicle in the state last year with 128,923 registrations. The Model 3 sedan was the second best-selling BEV with 53,056 registrations. 
Why It Matters: Tesla&#8217;s fall in registrations in California is not inconsistent with its <a href="https://www.benzinga.com/25/01/43214246/researcher-expects-teslas-vehicle-deliveries-to-remain-flat-in-2025-contrary-to-musks-20-30-growth-prediction">overall performance last year</a>. 
The company reported a fall in vehicle deliveries for the first time in over a decade in 2024. Tesla reported global&nbsp;<a href="https://www.benzinga.com/trading-ideas/movers/25/01/42766117/tesla-stock-tumbles-on-q4-deliveries-whats-going-on" target="_blank" rel="noreferrer noopener">deliveries of 1.79 million</a>&nbsp;vehicles, down from full-year deliveries of 1.81 million in 2023, as the company attempted to ramp production of its refreshed Model 3 vehicle in a high interest rate environment. 
Tesla CEO Elon Musk&#8216;s <a href="https://www.benzinga.com/news/24/10/41479388/elon-musk-says-tesla-spacex-manufactured-in-costly-california-just-because-he-lived-there-even-as-ri">affiliation with Republican President Donald Trump</a> also likely didn&#8217;t fare well with customers of the brand in the democratic state. 
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43427393/tesla-rival-byd-marks-475-growth-in-january-passenger-vehicle-sales-driven-by-popularity-of-plug-in-hybrid-evs" target="_blank" rel="noreferrer noopener">Tesla Rival BYD Marks 47.5% Growth In January Passenger Vehicle Sales Driven By Popularity Of Plug-In Hybrid EVs</a></li>
</ul>
Photo courtesy: Tesla

Tech

TSLA

Tesla's Golden State Struggles: Registrations Decline In US' Largest EV Market For 5th Straight Quarter

Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) delivered a blockbuster <a href="https://www.benzinga.com/news/earnings/25/02/43449486/palantir-q4-earnings-revenue-beat-eps-beat-us-revenue-up-52-customer-count-up-43-strong-guidance-this-is-a-new-phase-unlike-anything-that-has-come-before">fourth-quarter performance</a>, positioning itself as a critical player in the artificial intelligence revolution with a 36% year-over-year revenue increase and aggressive growth across commercial and government sectors.
What Happened: The company reported fourth-quarter revenue of $827.52 million, significantly beating analyst estimates. U.S. commercial revenue soared 64% year-over-year, while the company&#8217;s total customer count expanded 43%, reflecting robust market demand for its AI platforms.
CEO Alex Karp emphasized the company&#8217;s transformative potential, stating Palantir is &#8220;making America more lethal&#8221; through its unique AI integration strategy. The company closed $1.8 billion in total contract value, with 32 deals exceeding $10 million each.
Notably, Palantir&#8217;s U.S. commercial segment saw unprecedented growth, expanding its customer base by 73% and achieving a 54% growth rate. The company&#8217;s proprietary &#8220;ontology&#8221; technology enables enterprises to effectively implement AI solutions, differentiating it from competitors.
See Also: <a href="https://www.benzinga.com/25/02/43452687/cathie-woods-ark-invest-dumps-lockheed-martin-shares-swoops-up-stock-of-this-satellite-phone-provider">Cathie Wood&#8217;s Ark Invest Dumps Lockheed Martin Shares, Swoops Up Stock Of This Satellite Phone Provider</a>
Why It Matters: Financial analysts are bullish on Palantir&#8217;s prospects. Wedbush Securities Managing Director Dan Ives described the earnings as a &#8220;massive AIP growth&#8221; and suggested the company could become &#8220;the next Oracle&#8221; with the potential for a <a href="https://www.benzinga.com/markets/equities/25/02/43452860/palantir-soars-23-after-hours-as-cramer-says-i-wont-let-you-down-and-dan-ives-calls-it-the-next-oracle-in-ai-boom">trillion-dollar market capitalization</a>.
The company&#8217;s forward guidance indicates continued momentum, with expected 2025 full-year revenue between $3.74 billion and $3.76 billion. Palantir also anticipates positive operating and net income in each quarter of 2025.
Price Action: Palantir's stock surged 22.75% to an all-time high of $102.79 in after-hours trading on Monday, following a 1.52% gain in the regular session, closing at $83.74, according to <a href="https://www.benzinga.com/pro/" target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/25/02/43453597/mohamed-el-erian-flags-market-jitters-as-tariff-pause-triggers-currency-swings-larry-summers-warns-of-trade-fallout">Mohamed El-Erian Flags Market Jitters As Trump Tariff Pause On Canada Triggers Currency Swings — Larry Summers Warns Of Trade Fallout</a></li>
</ul>
Image Via Shutterstock 
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

PLTR

Palantir Is 'Making America More Lethal' As Alex Karp-Led Company Secures $1.8 Billion in AI Contracts — US Commercial Customer Base Surges 73%

Prominent Wall Street short seller Jim Chanos has called attention to the billions in federal subsidies received by Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and its customers, amid growing scrutiny of CEO Elon Musk&#8216;s political activities and declining sales in key markets.
What Happened: Chanos&#8217;s comments came after Tesla&#8217;s Cybertruck was confirmed eligible for a $7,500 federal tax incentive, Cybertruck is now starting at $72,490. 
&#8220;While you work up (justifiable) outrage over the worst of USAID&#8217;s silly foreign grants, don&#8217;t forget to ignore the tens of billions of US Taxpayer dollars that Musk&#8217;s companies and customers continue to receive annually,&#8221; Chanos wrote on X.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">While you work up (justifiable) outrage over the worst of USAID's silly foreign grants, don't forget to ignore the tens of billions of US Taxpayer dollars that Musk's companies and customers continue to receive annually. <a href="https://t.co/1czps6fmlK">https://t.co/1czps6fmlK</a>
&mdash; James Chanos (@RealJimChanos) <a href="https://twitter.com/RealJimChanos/status/1886619965140107552?ref_src=twsrc%5Etfw">February 4, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The criticism follows Musk&#8217;s recent announcement that President Donald Trump agreed to shut down the U.S. Agency for International Development (USAID), an agency responsible for billions in humanitarian aid and development funding.
See Also: <a href="https://www.benzinga.com/markets/equities/25/02/43452860/palantir-soars-23-after-hours-as-cramer-says-i-wont-let-you-down-and-dan-ives-calls-it-the-next-oracle-in-ai-boom">Palantir Crosses $100 Mark In After-Hours Trading, Hits All-Time High — Jim Cramer Says &#8216;Won&#8217;t Let You Down&#8217;</a>
Why It Matters: Tesla&#8217;s political entanglements come as the company faces challenges in its <a href="https://www.benzinga.com/trading-ideas/25/02/43447273/tesla-sales-drop-12-in-california-is-elon-musks-support-for-donald-trump-hurting-ev-sales">largest EV market</a>. California registrations dropped 12% in 2024, outpacing the company&#8217;s national sales decline of 5.6%. The company&#8217;s market share of zero-emission vehicles in California fell from 60.1% to 52.5% year-over-year, according to the California New Car Dealers Association.
The sales decline coincides with Musk&#8217;s increased political involvement, including a reported $288 million investment in supporting Trump&#8217;s presidential campaign. Brand Finance <a href="https://www.benzinga.com/news/global/25/01/43172806/tesla-lost-15-billion-in-brand-value-in-2024-report-says-did-elon-musks-political-push-hurt-ev-giant">reports that Tesla&#8217;s brand value</a> decreased by $15 billion in 2024, dropping from 18th to 36th place in global brand rankings.
Adding to the complex political landscape, Musk has recently been appointed as a &#8220;special government employee&#8221; to lead Trump&#8217;s Department of Government Efficiency initiative. While unpaid, the position grants Musk significant <a href="https://www.benzinga.com/25/02/43452103/elon-musk-appointed-as-special-government-employee-amid-doge-department-push-cant-do-anything-without-our-approval-says-trump">oversight of federal systems</a> while potentially bypassing certain disclosure requirements typically applied to government employees.
Price Action: Tesla&#8217;s stock closed at $383.68 on Monday, down 5.17% for the day. In after-hours trading, the stock rebounded 1.39% to $389.01, according to <a href="https://www.benzinga.com/pro/" target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/02/43452791/bitcoin-ethereum-dogecoin-stage-strong-rebound-as-trump-pauses-canada-mexico-tariffs-analyst-flags-significance-of-101000-for-btc">Bitcoin, Ethereum, Dogecoin Stage Strong Rebound As Trump Pauses Canada, Mexico Tariffs: Analyst Flags Significance Of $101,000 For BTC</a></li>
</ul>
Image Via Shutterstock 
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Short Sellers

Jim Chanos Blasts Tesla's Billion-Dollar Subsidies As Cybertruck Secures $7,500 Incentive After Elon Musk's Call To Shut Down USAID

Ellington Credit Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EARN#NYSE">EARN</a>) ("we") today reported the following preliminary fourth quarter financial results, and update on its portfolio and pending conversion to a CLO closed-end fund.
<ul>
<li>Book value per common share is estimated to be in the range of $6.52 to $6.54 as of December 31, 2024, including the effects of dividends of $0.24 per common share declared during the quarter.</li>
<li>Net income (loss) per common share is estimated to be in the range of $(0.08) to $(0.06) for the quarter ended December 31, 2024.</li>
<li>Adjusted Distributable Earnings1 per common share is estimated to be in the range of $0.26 to $0.28 for the quarter ended December 31, 2024. Adjusted Distributable Earnings is a non-GAAP financial measure. See "Reconciliation of Adjusted Distributable Earnings to Net Income (Loss)" below for an explanation regarding the calculation of Adjusted Distributable Earnings.</li>
<li>Total shareholders' equity is estimated to be $195 million as of December 31, 2024.</li>
<li>CLO portfolio and MBS portfolio increased to approximately $170 million and $510 million, respectively, as of December 31, 2024.</li>
<li>Capital allocation2 to CLOs was approximately 72% as of December 31, 2024 as compared to 58% as of September 30, 2024.</li>
<li>Expected conversion to a closed-end fund on or before April 1, 2025.</li>
</ul>

EARN

Reported Earlier, Ellington Credit Reports Preliminary Q4 Adj. EPS Of $0.26-$0.28 (Vs. $0.30 Est.), Estimates Book Value At $6.52-$6.54, And Provides Conversion Update

Cryptocurrency analyst James Van Straten recommended having exposure to MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) in the newly announced U.S. sovereign wealth fund&nbsp;instead of spot Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) on Monday.
What Happened: In an X post, Van Straten weighed in on the potential equity exposure in the first-of-its-kind state-owned investment vehicle announced by President Donald Trump.
&#8220;I'd rather see the fund have exposure to MSTR through its convertible bonds than for it to buy BTC,&#8221; the analyst wrote.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">I imagine the sovereign wealth fund will have equity exposure. I'd rather see the fund have exposure to <a href="https://twitter.com/search?q=%24MSTR&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$MSTR</a> through its convertible bonds than for it to buy <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a>.
&mdash; James Van Straten (@btcjvs) <a href="https://twitter.com/btcjvs/status/1886523940757033117?ref_src=twsrc%5Etfw">February 3, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
When asked about the rationale behind proposing such an idea, Van Straten argued that accumulating large amounts of Bitcoin would significantly push the prices up, causing a potential problem for U.S.-based entities who routinely purchase the asset.
&#8220;All the BTC that is owned within the US &#8211; MSTR, ETFs etf is the US BTC IMO. You want to shore it all up,&#8221; he added. 
See Also:<a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading"> </a><a href="https://www.benzinga.com/25/02/43425216/elon-musk-supports-putting-treasury-department-operations-on-blockchain-to-fix-irregularities">Elon Musk Says Treasury Officials &#8216;Breaking The Law Every Hour&#8217; By Approving Fraudulent Payments — DOGE Lead Wants A Blockchain Fix</a>
Why It Matters: Van Straten&#8217;s comments come in the wake of the Trump administration&#8217;s plans to monetize government-owned assets to generate economic value for the American people. The sovereign fund <a href="https://in.benzinga.com/government/regulations/25/02/43447339/trump-announces-us-sovereign-wealth-fund-hints-at-tiktok-ownership">would hold a variety of "liquid assets" </a>and strategic holdings.
Speculations about the federal government&#8217;s investments in Bitcoin have soared since Trump took office. The president signed an executive order last month that will <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43177482/trump-signs-executive-order-on-crypto-bitcoin-reserve-to-be-evaluated">evaluate the creation</a> of a "strategic national digital assets stockpile."
Michael Saylor-led MicroStrategy has been on a Bitcoin buying spree, with the company&#8217;s stockpile&nbsp;<a href="https://bitcointreasuries.net/" target="_blank" rel="noreferrer noopener">growing&nbsp;</a>to 471,107 BTC, worth over $46.46 billion, as of this writing.
A key feature of this strategy is issuing convertible bonds at 0% interest to fund the purchases. However, <a href="https://www.benzinga.com/24/12/42735744/pharma-bro-martin-shkreli-predicts-doom-for-michael-saylors-microstrategy-as-stock-dips-below-300-in-after-hours-trading">skeptics have been critical</a>, warning of potential liquidations if Bitcoin&#8217;s value declines drastically.
Price Action: At the time of writing, Bitcoin was exchanging hands at $98,768.54, up 5.43% in the last 24 hours, according to&nbsp;<a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA.." target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Shares of MicroStrategy closed 3.67% higher at $347.09 during Monday's regular session.
The stock has a consensus price target of $454.54 based on the ratings of 13 analysts, with an average price target of $605 between Bernstein and Mizuho.
Photo by JOCA_PH on Shutterstock
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43423466/how-does-pete-hegseth-feel-about-bitcoin-his-financial-filings-reveal-the-answer">How Does Pete Hegseth Feel About Bitcoin? His Financial Filings Reveal The Answer</a></li>
</ul>

$BTC

MSTR

Trump-Announced Wealth Fund Should Choose MicroStrategy Bonds Over Bitcoin, Analyst Says

Edward Smolyansky said, "Lifeway seems determined to plunge the Company deeper and deeper into litigation this time via proxy by Julie. We look forward to providing all shareholders a fully transparent accounting of the inner workings of America's Worst Governed Publicly Traded Company."
Ludmila Smolyansky stated, "After they cut a check to Julie for $2 million, I anticipated that she would file a lawsuit against Edward the following month." Mrs. Smolyansky continued, "On January 23, Julie filed suit. In anticipation of this, on January 3, I began to sell some of my shares to defend Edward. I have no choice, as&nbsp;Lifeway's legal counsel has refused to provide the adequate paperwork to Edward to monetize his holdings in LWAY as permitted under our 1999 Shareholders Agreement between our family member and Group Danone

LWAY

Reported Earlier, Edward And Ludmila Smolyansky Demand Lifeway Foods CEO Ends Legal Battle

CALM

Reported Earlier, Cal-Maine Foods Acquires Two Feed Mills, Strengthening Production Efficiency

Liberty Energy announced that its Board of Directors (the "Board") has appointed Ron Gusek as Chief Executive Officer and as a member of the Board of Directors. Additionally, the Board has elected William Kimble as non-executive Chairman of the Board. These leadership transitions are concurrent with the confirmation of Chris Wright as U.S. Secretary of Energy. Mr. Wright, the founder of Liberty Energy, has served as Chairman of the Board, Director, and Chief Executive Officer since the Company's inception in 2011.

LBRT

Reported Earlier, Liberty Energy Names Ron Gusek As CEO, William Kimble As Chairman

The Company intends to use the net proceeds from the offering for working capital requirements, general corporate purposes, and the advancement of business objectives.

BCTX

Reported Earlier, BriaCell Prices $3.05M Public Offering Of 762,500 Common Shares At $4/Share

Reported Earlier, Noble Corporation Retires Two Drillships To Cut Costs And Streamline Fleet

PNTG

Reported Earlier, Pennant Acquires Three Senior Living Communities In Idaho And Texas To Expand Care Network

Econ #s

BBJP

WisdomTree Trust Japan Total Dividend Fund

Reported Earlier, Japan 10-Year JGB Auction 1.260% Vs. 1.140% Prior

19:50 EST Qualigen Therapeutics (QLGN) trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving br...

Qualigen Therapeutics trading halted, news pending

Qualigen Therapeutics ( ($QLGN) ) has issued an update. Graydon Bensler has been appointed as an independent board member, bringing over seven year...

Qualigen Therapeutics Appoints Graydon Bensler to Board

Qualigen Therapeutics (QLGN) has entered into definitive securities purchase agreements with several institutional and accredited investors for the...

Qualigen announces $4.5M private placement of Preferred Shares

Qualigen Therapeutics announces $4.5M private placement of convertible preferred shares

Qualigen Therapeutics (QLGN) announced that the Company received formal notice from The Nasdaq Stock Market that the Company has regained complianc...

Qualigen Therapeutics regains compliance with Nasdaq's min bid price

Qualigen Therapeutics regains compliance with Nasdaq's listing requirements

Qualigen Therapeutics (QLGN) announced they will be the first investors participating in the 2025 bridge round of funding for NanoSynex. NanoSynex ...

Qualigen Therapeutics to participate in next funding round for NanoSynex

Qualigen Therapeutics ( ($QLGN) ) just unveiled an update. On January 28, 2025, Qualigen Therapeutics announced its participation as the first inve...

Qualigen Therapeutics Invests in NanoSynex's Growth

Qualigen to invest in NanoSynex, stock tumbles 21%

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include:&nbsp...

Comments

Qualigen Therapeutics

Interés en corto

Qualigen Therapeutics (NASDAQ:QLGN) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL